I just got home from the very epicenter of America's legal cannabis sector – Oakland, Calif. I have one heck of a head cold right now… yet I've been bouncing all week.
That's because we just closed out the fourth annual Cannabis Business Summit & Expo, probably the biggest, most important legal weed conclave of the year.
We got the chance to talk to some of the giants of cannabis – former president of Mexico and cannabis bull Vicente Fox, for one, and Taylor West of the National Cannabis Industry Association, to name another…
Interestingly enough, two of the most significant (read: profitable) developments I've uncovered for investors weren't all that flashy.
They're interconnected issues that might not blow your hair back at first, but they're pointing to one of the most unusual "pot stock" recommendations I've ever made…
For Investors, These Details Matter
So, here's the really "boring" thing I have to tell you about today.
I'm talking about government compliance and product/service/results-based tracking. These are urgent needs in the cannabis sector right now, and it happens to be exactly why – right alongside all the growers and dispensaries that you'd expect – so many software companies were at this expo.
You see, most pot entrepreneurs start out with little experience in complying with state and local government rules or tracking their products. Plus, when they're just starting out, they don't have the staff to handle this kind of "boring" bureaucratic stuff.
And that boring bureaucratic stuff is critically important in such a brand-new, relatively controversial industry that was, let's face it, almost totally illegal just five years ago.
These businesses need to have all t's crossed and all i's dotted, lest they face crippling, potentially business-ending sanctions.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.